Literature DB >> 21930349

Immunohistochemical expression of proinflammatory cytokines IL-1β, IL-6, TNF-α and involvement of COX-2, quantitatively confirmed by Western blot analysis, in Wernicke's encephalopathy.

Margherita Neri1, Santina Cantatore, Cristoforo Pomara, Irene Riezzo, Stefania Bello, Emanuela Turillazzi, Vittorio Fineschi.   

Abstract

Selective cerebral vulnerability is a major consequence of Wernicke's encephalopathy (WE), in which focal areas of the brain exhibit symmetrical profound neuronal loss and accompanying gliosis, occurring most frequently in diencephalic regions such as the thalamus and the mammillary bodies. Many processes have been proposed to explain the selective cerebral vulnerability and the focal neuronal cell death in Wernicke's encephalopathy. There are several mechanisms which are common to the pathophysiology of encephalopathies caused by thiamine deficiency (TD). Recently, emphasis is being placed on deficit in mitochondrial oxidative metabolism, oxidative/nitrosative stress, and the release of proinflammatory cytokines such as IL-1β, IL-6, and tumor necrosis factor-α (TNF-α). Cyclooxygenase-2 (COX-2) plays major roles in regulating brain damage and inflammation. Here we present two fatal cases of non-alcohol associated WE. The immunohistochemical study revealed increased proinflammatory cytokine immunoreactivity in the neurons of the mammillary bodies and medial thalamus, and in the periaqueductal regions, compared with basal constitutive levels of expression in the frontal cortex. Positive (WE cases) and negative (immediate trauma deaths) case-controls were used to confirm the results. TD induced IL-1β proteins weakly, while moderate increase was observed for TNF-α and IL-6. Immunofluorescence analysis by confocal microscopy confirmed the staining results for immunoreactivity in WE brains. Further, the induction of proinflammatory cytokine protein expression levels was quantified by Western blot analysis. Copyright Â
© 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930349     DOI: 10.1016/j.prp.2011.07.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  11 in total

Review 1.  Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.

Authors:  Eman Abdou; Alan S Hazell
Journal:  Neurochem Res       Date:  2014-10-09       Impact factor: 3.996

2.  Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.

Authors:  Katharina Wolf; Thomas Schmitt-Mechelke; Spyridon Kollias; Armin Curt
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

Review 3.  Wernicke's encephalopathy: expanding the diagnostic toolbox.

Authors:  Mary E Lough
Journal:  Neuropsychol Rev       Date:  2012-05-11       Impact factor: 7.444

4.  Cytokines, chaperones and neuroinflammatory responses in heroin-related death: what can we learn from different patterns of cellular expression?

Authors:  Margherita Neri; Laura Panata; Mauro Bacci; Carmela Fiore; Irene Riezzo; Emanuela Turillazzi; Vittorio Fineschi
Journal:  Int J Mol Sci       Date:  2013-09-30       Impact factor: 5.923

5.  Early Loss of Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model of Psychosis.

Authors:  Stefania Schiavone; Emanuela Mhillaj; Margherita Neri; Maria Grazia Morgese; Paolo Tucci; Maria Bove; Mario Valentino; Giuseppe Di Giovanni; Cristoforo Pomara; Emanuela Turillazzi; Luigia Trabace; Vincenzo Cuomo
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

6.  Could Vitamins Help in the Fight Against COVID-19?

Authors:  Thomas H Jovic; Stephen R Ali; Nader Ibrahim; Zita M Jessop; Sam P Tarassoli; Thomas D Dobbs; Patrick Holford; Catherine A Thornton; Iain S Whitaker
Journal:  Nutrients       Date:  2020-08-23       Impact factor: 6.706

7.  Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile.

Authors:  Vatsalya Vatsalya; Fengyuan Li; Jane Frimodig; Khushboo S Gala; Shweta Srivastava; Maiying Kong; Vijay A Ramchandani; Wenke Feng; Xiang Zhang; Craig J McClain
Journal:  Front Pharmacol       Date:  2021-03-02       Impact factor: 5.810

Review 8.  Beneficial Effects of Vitamins, Minerals, and Bioactive Peptides on Strengthening the Immune System Against COVID-19 and the Role of Cow's Milk in the Supply of These Nutrients.

Authors:  M R Rezaei Ahvanooei; Mohammad Ali Norouzian; Payam Vahmani
Journal:  Biol Trace Elem Res       Date:  2021-11-27       Impact factor: 4.081

9.  Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity.

Authors:  Natalie M Zahr; Kilian M Pohl; Allison J Kwong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 6.208

10.  Losartan protects against osteoarthritis by repressing the TGF-β1 signaling pathway via upregulation of PPARγ.

Authors:  Zhenhan Deng; Fei Chen; Yuwei Liu; Jinping Wang; Wei Lu; Wei Jiang; Weimin Zhu
Journal:  J Orthop Translat       Date:  2021-05-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.